Ironwood Pharmaceuticals (IRWD) Receivables (2016 - 2026)
Ironwood Pharmaceuticals' Receivables history spans 16 years, with the latest figure at $46.7 million for Q4 2025.
- On a quarterly basis, Receivables fell 42.97% to $46.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $46.7 million, a 42.97% decrease, with the full-year FY2025 number at $46.7 million, down 42.97% from a year prior.
- Receivables hit $46.7 million in Q4 2025 for Ironwood Pharmaceuticals, down from $120.4 million in the prior quarter.
- Over the last five years, Receivables for IRWD hit a ceiling of $129.1 million in Q4 2023 and a floor of $39.8 million in Q1 2025.
- Historically, Receivables has averaged $100.7 million across 5 years, with a median of $115.6 million in 2022.
- Biggest five-year swings in Receivables: crashed 51.17% in 2024 and later skyrocketed 58.0% in 2025.
- Tracing IRWD's Receivables over 5 years: stood at $114.0 million in 2021, then rose by 1.24% to $115.5 million in 2022, then grew by 11.82% to $129.1 million in 2023, then crashed by 36.57% to $81.9 million in 2024, then plummeted by 42.97% to $46.7 million in 2025.
- Business Quant data shows Receivables for IRWD at $46.7 million in Q4 2025, $120.4 million in Q3 2025, and $86.2 million in Q2 2025.